Randomized study of efficacy of flushing to avoid venous pain in colorectal or gastric cancer patients who are receiving oxaliplatin through peripheral vein

Randomized study of efficacy of flushing to avoid venous pain in colorectal or gastric cancer patients who are receiving oxaliplatin through peripheral vein - Randomized study of efficacy of flushing to avoid venous pain with oxaliplatin infusion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016610

Enrollment

Registered

2015-03-02

Start date

2015-03-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive system cancer

Interventions

1st cycle : normal saline solution 2nd cycle : 5% glucose solution 1st cycle : 5% glucose solution 2nd cycle : normal saline solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) colorectal/gastric cancer who first receive 130mg/m2 of oxaliplatin through peripheral vein 2) Staging no object 3) Patients who give written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1) the patient who have experienced severe or irreversible application site pain in past time 2) the patient who were judged to be inappropriate as subjects by the study investigators

Design outcomes

Primary

Measure	Time frame
To evaluate the application site pain with NRS	—

Secondary

Measure	Time frame
site of sideration, time of onset, duration of onset, injection site reaction, alleviation of symptom	—

Countries

Japan

Contacts

Public ContactMasayo Okawa

Hitachi,Ltd.,Hitachi General Hospital clinical research center

masayo.okawa.ne@hitachi.com0294-23-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026